Reduced apoptosis by pentoxiphylline among patients with HIV infection

International Immunopharmacology

Volumn 3, Issue 3, 2003, Pages 359-364

  Wanchu, A ^a   Bhatnagar, A ^a   Kumar, B ^a   Bambery, P ^a   Singh, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Caspase; HIV infection; Pentoxiphylline

Indexed keywords

CASPASE 8; CD4 ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; PENTOXIFYLLINE;

ADULT; APOPTOSIS; ARTICLE; CELL COUNT; CELL POPULATION; CELL SURVIVAL; CLINICAL ARTICLE; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0037333925     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00252-7     Document Type: Article

References (41)

1. Biberfeld P., Chayt K.J., Marselle L.M.et al. HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am. J. Pathol. 125:1986;436-442.
2. Ledru E., Lecoeur H., Garcia S., Debord T., Gougeon M.L.J. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl2 expression and consequences to AIDS pathogenesis. Immunology. 160:1998;3194-3206.
3. Ameison J.C., Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today. 12:1991;102-105.
4. Bartz S.R., Emerman M. Human immunodeficiency virus type 1 induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE-caspase-8. J. Virol. 73:1999;1956-1963.
5. Yao X.J., Mouland A.J., Subbramanian R.A., Forget J., Rougeau N.et al. Vpr stimulates viral expression and induces cell killing in human immunodeficiency type 1 infected dividing Jukrat T cells. J. Virol. 72:1998;4686-4693.
6. Poon B., Grovit-Ferbas K., Stewart S.A., Chen I.S.Y. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science. 281:1998;266-299.
7. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
8. Scaffidi C., Fulda S., Srinivasan A.et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1998;1675-1687.
9. Darnay B.G., Aggarwal B.B. Early events in TNF signaling: a story of associations and dissociations. J. Leukoc. Biol. 61:1997;559-566.
10. Wiley S.R., Schooley K., Smolak P.J.et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682.
11. Tanaka M., Suda T., Haze K.et al. Fas ligand in human serum. Nat. Med. 2:1996;317-322.
12. McGeehan G.M.et al. Regulation of tumor necrosis factor: a processing by a metalloproteinase inhibitor. Nature. 370:1994;558-561.
13. Chinnaiyan A.M., Tepper C.G., Seldin M.F.et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
14. Hsu H., Shu H.-B., Pan M.-G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
15. Scaffidi C., Medema J.P., Krammer P.H., Peter M.E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8A and caspase-8/b. J. Biol. Chem. 272:1997;26953-26958.
16. Fernandes-Alnemri T., Armstrong R.C., Krebs J.et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FAD-like domains. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7464-7469.
17. Rosen A., Casciola-Rosen L. Macromolecular substrates for the ICE-like proteases during apoptosis. J. Cell. Biochem. 64:1997;50-54.
18. Sloand E.M., Maciejewski J.P., Tadatsugu S., Bruny J., Kumar P., Kim S. The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J. Clin. Invest. 101:1998;195.
19. + T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood. 87:1996;4959.
20. Wanchu A., Khullar M., Bhatnagar A., Sud A., Bambery P., Singh S. Pentoxiphylline reduces nitric oxide production among patients with HIV infection. Immunol. Lett. 74:2000;121-125.
21. Wanchu A., Arora S., Bhatnagar A., Sud A., Bambery P., Singh S. Suppression of beta-2 microglobulin by pentoxiphylline therapy in asymptomatic HIV infected individuals. Indian J. Med. Res. 113:2001;75-77.
22. Eigler A., Sinha B., Hartmann G., Endres A., Taming T.N.F. Strategies to restrain this proinflammatory cytokine. Immunol. Today. 18:1997;487-492.
23. Han J., Thompson P., Bewtler B. Dexamethasone and pentoxyphylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signalling pathway. J. Exp. Med. 170:1998;391-394.
24. Weinsch C., Looreeserwan D., Wilairatana P.et al. Effect of pentoxiphylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 58:1998;343-347.
25. Navarro J., Punzon M.C., Piazarro A., Fernandez-Cruz E., Fresno M., Munoz-Fernandez M.A. Pentoxiphylline inhibits acute HIV-1 replication in human T cells by mechanism not involving inhibition of tumor necrosis factor synthesis or nuclear factor-kappa B activation. AIDS. 10:1996;469-475.
26. Alderson M.R., Tough T.W., Davis-Smith T., Braddy S., Falk B.et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:1995;71-77.
27. Los M., Van de Craen M., Penning L.C., Schenk H., Westendorp M.et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature. 375:1995;81-83.
28. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J.et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 267:1995;2000-2003.
29. Enari M., Hug H., Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78-81.
30. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z.et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
31. Mashima T., Naito M., Fujita N., Noguchi K., Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. Biophys. Res. Commun. 217:1995;1185-1192.
32. Nicholson D., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K.et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
33. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
34. + T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood. 87:1996;4959-4966.
35. Selleri C., Sato T., del Vecchio L., Luciano L., Barrett A.J.et al. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia. Blood. 89:1997;957-964.
36. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 85:1995;3183-3190.
37. Wanchu A., Bhatnagar A., Arora S., Khullar M., Sud A., Bambery P.et al. Pentoxiphylline in the prevention of opportunistic infections: a panacea for the economically underprivileged? International Meeting of the Institute of Human Virology, Baltimore, USA:2000;. Abstract No. 293.
38. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512.
39. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:1998;2926-2930.
40. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
41. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Litwack G., Alnemri E.S. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14486-14491.